Pipeline Watch
11 September 2009
A busy week is recorded in this issue’s Pipeline Watch, especially for licensing agreements in the cardiovascular and metabolic segments. Other highlights from the table not previously reported in Scrip include another deal, this time between Endo Pharmaceuticals and ProStrakan. Endo is to pay...
Please Login to read the full article.
11 September 2009
A busy week is recorded in this issue’s Pipeline Watch, especially for licensing agreements in the cardiovascular and metabolic segments. Other highlights from the table not previously reported in Scrip include another deal, this time between Endo Pharmaceuticals and ProStrakan. Endo is to pay...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Scotland says no to Halaven for breast cancer and yes to Levitra for erectile dysfunction
- US Capitol Capsule: Will sequestration be a better outcome for biopharma?
- Bayer licenses non-US/EU rights to Trius' torezolid for $25M up front
- US Capitol Capsule: Zombies, doomsday and debt ceilings, oh my
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
